No Data
No Data
No Data
No Data
No Data
泰凌醫藥:2023 年報
Futu NewsApr 30 05:00 ET · Announcements
Tailing Pharmaceutical (01011) announced annual results. Shareholders' losses of 144 million yuan increased by 116.23% year-on-year
According to the Zhitong Finance App, Tailing Pharmaceutical (01011) announced the audited annual results for the year ended December 31, 2023. The group achieved continuous business revenue of 7.366 million yuan (RMB, same below) during the period, with no revenue in the same period of the previous year; shareholders should have accounted for a loss of 144 million yuan, an increase of 116.23% over the previous year; and a basic loss of 7.26 points per share. The announcement stated that the increase in revenue was due to a change in the business model in 2023.
Zhitong FinanceMar 28 11:54 ET
泰凌醫藥:截至2023 年12 月31日止年度經審核全年業績公告
Futu NewsMar 28 09:35 ET · Announcements
China NT Pharma Group Company Limited (HKG:1011) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
Unfortunately for some shareholders, the China NT Pharma Group Company Limited (HKG:1011) share price has dived 30% in the last thirty days, prolonging recent pain. The recent drop completes a disa
Simply Wall StMar 21 18:49 ET
Tailing Pharmaceutical (01011.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Gelonghui, March 19, 丨 Tailing Pharmaceutical (01011.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results of the company and its subsidiaries for the year ended December 31, 2023.
Gelonghui FinanceMar 19 06:00 ET
NT PHARMA: DATE OF BOARD MEETING
Futu NewsMar 19 05:59 ET · Announcements
No Data
No Data